Skip to main content

Agendia Gets ISO Accreditation for CupPrint

NEW YORK (GenomeWeb News) - Agendia has acquired ISO/IEC 17025:2005 accreditation for its CupPrint microarray service from the Dutch Accreditation Council, the company said today.
 
The company was granted ISO 17025 accreditations for MammaPrint, a microarray-based breast cancer diagnostic, in Sept. 2005. According to Agendia, it is the first company to receive this accreditation for the test.
 
CupPrint is a test for cancer of unknown primary.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.